Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 51-75 of 1150 citing articles:

Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study
Christian R. Kahlert, Carol Strahm, Sabine Güsewell, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 2, pp. 194-202
Open Access | Times Cited: 44
Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland
Lea Portmann, Marlieke E.A. de Kraker, Georg Fröhlich, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2255599-e2255599
Open Access | Times Cited: 41
COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada
Taraneh Bahremand, Jiayun Yao, Christopher Mill, et al.
The Lancet Regional Health - Americas (2023) Vol. 20, pp. 100461-100461
Open Access | Times Cited: 41
Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study
Matthieu Schmidt, David Hajage, Micha Landoll, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 2, pp. 163-175
Open Access | Times Cited: 39
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study
Margaux M. I. Meslé, Jeremy Brown, Piers Mook, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 9, pp. 714-727
Closed Access | Times Cited: 23
Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity
Zemin Yang, Bryan A. Johnson, Victoria Meliopoulos, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113965-113965
Open Access | Times Cited: 22
Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis
Francesca Gioia, Laura N. Walti, Ani Orchanian‐Cheff, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 3, pp. 207-216
Closed Access | Times Cited: 20
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study
Huwen Wang, Yuchen Wei, C.T. Hung, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 13
Comparative Study of Cytokine Profiles in SARS-CoV-2 Delta and Omicron Variants
Michaela Krivosova, Juliana Hanusrichterová, Vincent Lučanský, et al.
Bratislavské lekárske listy/Bratislava medical journal (2025)
Open Access | Times Cited: 1
Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
Yeonju La, Won Sup Oh, Changhyup Kim, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Karina-Doris Vihta, Koen B. Pouwels, Tim Peto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 65
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
Ola Blennow, Jon Salmanton‐García, Piotr Nowak, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 8
Open Access | Times Cited: 65
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 65
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 63
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study
Vincent Auvigne, Sophie Vaux, Yann Le Strat, et al.
EClinicalMedicine (2022) Vol. 48, pp. 101455-101455
Open Access | Times Cited: 62
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore
Oon Tek Ng, Kalisvar Marimuthu, Nigel Wei-Han Lim, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2228900-e2228900
Open Access | Times Cited: 62
Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
Jianguo Zhang, Nan Chen, Daguo Zhao, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 61
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study
Sarah J. Stock, Emily Moore, Clara Calvert, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1129-1136
Open Access | Times Cited: 58
Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study
Jacek Skarbinski, Mariah S. Wood, Tyler C. Chervo, et al.
The Lancet Regional Health - Americas (2022) Vol. 12, pp. 100297-100297
Open Access | Times Cited: 57
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection
Mathias Martins, Gabriela Mansano do Nascimento, Mohammed Nooruzzaman, et al.
Journal of Virology (2022) Vol. 96, Iss. 17
Open Access | Times Cited: 57
Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave
Javier T Solera, Berta G. Árbol, Abdullah M. Al-Shahrani, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 12, pp. 2193-2200
Open Access | Times Cited: 56
Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections
Winnie W. Y. Tso, Mike Yat Wah Kwan, Yu Liang Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1742-1750
Open Access | Times Cited: 56
The Race for Global Equitable Access to COVID-19 Vaccines
Lukman Nul Hakim Md Khairi, Mathumalar Loganathan Fahrni, Antonio Ivan Lazzarino
Vaccines (2022) Vol. 10, Iss. 8, pp. 1306-1306
Open Access | Times Cited: 56
BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality
Min Kyung Jung, Seong Dong Jeong, Ji Yun Noh, et al.
Nature Microbiology (2022) Vol. 7, Iss. 6, pp. 909-917
Open Access | Times Cited: 55

Scroll to top